Christiana Care seeks FDA approval for CRISPR cancer trial - Technical.ly Delaware

Sciences

Apr. 30, 2019 4:37 pm

Christiana Care seeks FDA approval for CRISPR cancer trial

The gene editing tool could potentially save lives.
Gene editing could be used to fight cancer before long.

Gene editing could be used to fight cancer before long.

(Screenshot via YouTube)

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), the gene-editing tool, has been the subject of countless debates on the ethical use of a technology that can actually alter DNA — with some foreseeing a dystopia of custom-ordered babies and miniature giraffes as pets.

Less dystopian are the potential medical benefits of CRISPR, which is why the Christiana Care Health System’s Gene Editing Institute is in the process of developing its first clinical trial that would use CRISPR on patients, after conducting successful lab trials. (You can read the December 2018 proof of concept paper on Molecular Therapy Oncolytics.)

The institute recently filed a preliminary investigational new drug application (IND) with the U.S. Food and Drug Administration. If approved, the trial, which focuses on treatment of  KRAS-positive non-small cell lung cancer, would have cleared a major hurdle in starting the trial.

“This exciting study represents a trio of firsts,” said Nicholas J. Petrelli, M.D., FACS, medical director of Christiana Care’s Helen F. Graham Cancer Center & Research Institute, in a statement. “It will be the first lung cancer clinical trial carried out by a gene editing program embedded in a community cancer center. While our Gene Editing Institute has a great deal of translational research experience, this will be its first study to move scientific discovery toward an IND application.

“And, it will also be the first time that we will be investigating technology that was grown organically at the Gene Editing Institute.”

You can learn more about CRISPR here:

Advertisement

Companies: ChristianaCare
-30-
CONTRIBUTE TO THE
JOURNALISM FUND

Already a contributor? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

CRISPR gene editing in Delaware: ‘It’s bigger than just the technology’

‘Stop asking for permission’ and other advice from women making a difference

Delaware State University leads biopharma talent development project

SPONSORED

Delaware

These hiring companies want to meet you at NET/WORK Suburbs

Horsham

Penn Mutual Life Insurance Co

Product Systems Specialist

Apply Now

Philadelphia, PA - Center City

Odessa

Sr. Project Manager – ERP Implementations

Apply Now

Philadelphia, PA

Vistar Media

QA Engineer

Apply Now

What is Delaware’s next big thing?

Prelude Therapeutics lands $60 million in Series B funding

FMC is investing $50 million into its Newark agtech research facility

SPONSORED

Delaware

Mastering the ‘halo effect’ in tech recruiting

Philadelphia, PA - Center City

Odessa

Business Architect

Apply Now

Philadelphia

Vistar Media

Sr. Software Engineer

Apply Now

Philadelphia

Vistar Media

Front End Engineer

Apply Now

Sign-up for daily news updates from Technical.ly Delaware

Do NOT follow this link or you will be banned from the site!